Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
Open Access
Abstract
The universal second messenger cAMP regulates diverse intracellular processes by interacting with ubiquitously expressed proteins, such as Protein Kinase A (PKA) and the Exchange Protein directly Activated by cAMP (EPAC). EPAC is implicated in multiple pathologies, thus several EPAC-specific inhibitors have been identified in recent years. However, the mechanisms and molecular interactions underlying the EPAC inhibition elicited by such compounds are still poorly understood. Additionally, being hydrophobic low molecular weight species, EPAC-specific inhibitors are prone to forming colloidal aggregates, which result in non-specific aggregation-based inhibition (ABI) in aqueous systems. Here, we review from a biophysical perspective the molecular basis of the specific and non-specific interactions of two EPAC antagonists—CE3F4R, a non-competitive inhibitor, and ESI-09, a competitive inhibitor of EPAC. Additionally, we discuss the value of common ABI attenuators (e.g., TX and HSA) to reduce false positives at the expense of introducing false negatives when screening aggregation-prone compounds. We hope this review provides the EPAC community effective criteria to evaluate similar compounds, aiding in the optimization of existing drug leads, and informing the development of the next generation of EPAC-specific inhibitors.Keywords
Funding Information
- Canadian Institutes of Health Research (389522)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-04514)
This publication has 94 references indexed in Scilit:
- Epac-Inhibitors: Facts and ArtefactsScientific Reports, 2013
- Isoform-specific antagonists of exchange proteins directly activated by cAMPProceedings of the National Academy of Sciences, 2012
- Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell CultureACS Chemical Biology, 2012
- 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMPBioorganic & Medicinal Chemistry Letters, 2012
- The Projection Analysis of NMR Chemical Shifts Reveals Extended EPAC Autoinhibition DeterminantsBiophysical Journal, 2012
- Promiscuous Aggregate-Based Inhibitors Promote Enzyme UnfoldingJournal of Medicinal Chemistry, 2009
- Epac signaling is required for hippocampus-dependent memory retrievalProceedings of the National Academy of Sciences, 2008
- Structure of Epac2 in complex with a cyclic AMP analogue and RAP1BNature, 2008
- Dissecting the Mechanism of Epac Activation via Hydrogen−Deuterium Exchange FT-IR and Structural ModelingBiochemistry, 2006
- Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited stateNature, 2006